The free research report on LJPC is available at: Shares in Henderson, Nevada headquartered Spectrum …
La Jolla Pharmaceutical Company (NASDAQ:LJPC)’s Director and one of the major shareholders ... However, it …
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla” or the “Company), a …
The earnings yield can be used to compare the earnings of a stock, sector or the whole market against bond yields. Generally, the earnings yields of equities are higher than the yield of risk-free treasury bonds. Financial theorists argue …
LJPC is ahead its 52-week low with 146.49%and going up from ... Latanoprostenebunod was licensed by Nicox to …
The news wiped out almost 90 percent of the San Diego-based company’s stock market value, driving shares down to 26 cents after the opening bell. The company (NASDAQ: LJPC) issued a one-paragraph statement this morning that said …
La Jolla Pharmaceutical plans to sell $100 million of its stock in a public offering ... along with expenses related to potential approval of LJPC-501 for potential treatment of catecholamine resistant hypotension. This life-threatening condition can ...
After announcing that its phase 3 ATHOS-3 study would be published in a prestigious medical journal, clinical-stage biotech La Jolla Pharmaceutical (NASDAQ: LJPC) saw its shares ... David and Tom Gardner have a stock tip, it can …
The Company's common stock is traded on The NASDAQ Global Market under the symbol LJPC. More information about the Company is available on its Web site: http://www.ljpc.com. The forward-looking statements in this press release …
La Jolla Pharmaceutical Company (Nasdaq: LJPC ... the pricing of an underwritten public offering of approximately 3.7 million shares of common stock, offered at a price of $33.50 per share, for gross proceeds of $125 million. In addition, …